128 related articles for article (PubMed ID: 10695995)
1. p21 expression is a prognostic factor in patients with p53-negative gastric cancer.
Xiangming C; Hokita S; Natsugoe S; Tanabe G; Baba M; Takao S; Kuroshima K; Aikou T
Cancer Lett; 2000 Feb; 148(2):181-8. PubMed ID: 10695995
[TBL] [Abstract][Full Text] [Related]
2. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma.
Gomyo Y; Ikeda M; Osaki M; Tatebe S; Tsujitani S; Ikeguchi M; Kaibara N; Ito H
Cancer; 1997 Jun; 79(11):2067-72. PubMed ID: 9179052
[TBL] [Abstract][Full Text] [Related]
3. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
[TBL] [Abstract][Full Text] [Related]
4. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma.
Natsugoe S; Nakashima S; Matsumoto M; Xiangming C; Okumura H; Kijima F; Ishigami S; Takebayashi Y; Baba M; Takao S; Aikou T
Clin Cancer Res; 1999 Sep; 5(9):2445-9. PubMed ID: 10499617
[TBL] [Abstract][Full Text] [Related]
5. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
6. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
[TBL] [Abstract][Full Text] [Related]
7. A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis.
Ogawa M; Onoda N; Maeda K; Kato Y; Nakata B; Kang SM; Sowa M; Hirakawa K
Int J Mol Med; 2001 May; 7(5):479-83. PubMed ID: 11295107
[TBL] [Abstract][Full Text] [Related]
8. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.
Migaldi M; Sgambato A; Garagnani L; Ardito R; Ferrari P; De Gaetani C; Cittadini A; Trentini GP
Clin Cancer Res; 2000 Aug; 6(8):3131-8. PubMed ID: 10955794
[TBL] [Abstract][Full Text] [Related]
9. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma.
Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
Dig Dis Sci; 1998 May; 43(5):964-70. PubMed ID: 9590408
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the long-term effects of intraperitoneal chemotherapy and the expression of p53 and p21 in patients with gastric carcinoma at stage IIIa and stage IIIb.
Ikeguchi M; Saito H; Katano K; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Int Surg; 1997; 82(2):170-4. PubMed ID: 9331847
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p21 and p53 expression in gastric cancer.
Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.
Fujino M; Dosaka-Akita H; Harada M; Hiroumi H; Kinoshita I; Akie K; Kawakami Y
Cancer; 1995 Dec; 76(12):2457-63. PubMed ID: 8625071
[TBL] [Abstract][Full Text] [Related]
14. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
Pasz-Walczak G; Kordek R; Faflik M
Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
[TBL] [Abstract][Full Text] [Related]
15. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.
Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K
Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma].
Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928
[TBL] [Abstract][Full Text] [Related]
17. Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma.
Okuyama T; Maehara Y; Kabashima A; Takahashi I; Kakeji Y; Sugimachi K
Oncology; 2002; 63(4):353-61. PubMed ID: 12417790
[TBL] [Abstract][Full Text] [Related]
18. Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation.
Omar EA; Behlouli H; Chevalier S; Aprikian AG
Prostate; 2001 Nov; 49(3):191-9. PubMed ID: 11746264
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas.
Kudo Y; Takata T; Ogawa I; Sato S; Nikai H
Oncol Rep; 1999; 6(3):539-45. PubMed ID: 10203588
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]